Caerus Investment Advisors »

BioMarin Pharmaceutical shares owned by Caerus Investment Advisors

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Caerus Investment Advisors from 13F filings

Historical chart of Caerus Investment Advisors investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Caerus Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Caerus Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $539k 10k 54.16

More positions owned by Caerus Investment Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Global X Fds S&p 500 Covered (XYLD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Global X Fds Nasdaq 100 Cover (QYLD)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Msci Eafe Etf (EFA)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Alphabet Cap Stk Cl A (GOOGL)
Dimensional Etf Trust Us Equity Market (DFUS)
Microsoft Corporation (MSFT)
Palantir Technologies Cl A (PLTR)

View all positions for Caerus Investment Advisors

Top funds holding BioMarin Pharmaceutical

BlackRock
Vanguard Group
PRIMECAP Management Company
Dodge & Cox
State Street Corporation
Viking Global Investors
AQR Capital Management
Geode Capital Management
Millennium Management
Capital Research Global Investors
UBS Group
Goldman Sachs Group
Dimensional Fund Advisors
Renaissance Technologies
Northern Trust

View all funds holding BioMarin Pharmaceutical